Sage Journals: Discover world-class research

Retricted access

Letter

First published 1979-2

Non-FDA Approved Drug Indications

Arthur Isbit

Annals of Pharmacotherapy

Retricted access

News

First published 2016-7

FDA Approves First Liquid Biopsy CDx for Non-Small Cell Lung Cancer

Inside Precision Medicine

Retricted access

Research article

First published 2011-3

Evaluation of Recombinant Factor VIIa Off-Label Use at an Acute Care Hospital with Established Guidelines for Use

John Allen, Earnest Alexander

Hospital Pharmacy

Retricted access

Research article

First published 2016-11

FDA safety actions for antidiabetic drugs marketed in the US,1980–2015

Christina S. Kwon, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio

International Journal of Risk & Safety in Medicine

Retricted access

Research article

First published 2011-3

Parental Preferences for FDA-Approved Medications Prescribed for Their Children

Esther Y. Yoon, Sarah J. Clark, Amy Butchart [...]

Clinical Pediatrics

Open access

Review article

First published 2025-9

Importance of FDA-Integrated Continuous Glucose Monitors to Ensure Accuracy of Continuous Glucose Monitoring

David C. Klonoff, Monica Gabbay, Sun Joon Moon [...]

Journal of Diabetes Science and Technology

Open access

Research article

First published 2020-2

The will of Congress? Permissive regulation and the strategic use of labeling for the anti-influenza drug Relenza

Shai Mulinari, Courtney Davis

Social Studies of Science

Retricted access

Research article

First published 1998-12

Off-label Prescribing of Antidepressants and Anxiolytics: An Attorney's Guide to Psychoactive Drugs

Richard M. Kuntz

The Journal of Psychiatry & Law

Retricted access

Research article

First published 2018-9

Investigating the Food and Drug Administration (FDA) Biotherapeutics Review and Approval Process: A Scoping Review

Samuel A. Bonet, Farzan Sasangohar, Mark Lawley

Proceedings of the Human Factors and Ergonomics Society Annual Meeting

Retricted access

Research article

First published 2019-7

Managing the Risks of Medicines: An Examination of FDA’s Application of Criteria for Requiring a REMS

Paul J. Seligman, Rebekah H. Anguiano, Thomas Felix [...]

Therapeutic Innovation & Regulatory Science

Search results